Signal therapy of breast cancers by the HDAC inhibitor FK228 that blocks the activation of PAK1 and abrogates the tamoxifen-resistance (Q40388273)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Signal therapy of breast cancers by the HDAC inhibitor FK228 that blocks the activation of PAK1 and abrogates the tamoxifen-resistance |
scientific article |
Statements
1 reference
Signal therapy of breast cancers by the HDAC inhibitor FK228 that blocks the activation of PAK1 and abrogates the tamoxifen-resistance (English)
1 reference
John Zalcberg
1 reference
Yumiko Hirokawa
1 reference
Melissa Arnold
1 reference
Hidenori Nakajima
1 reference
Hiroshi Maruta
1 reference
13 September 2005
1 reference
1 reference
Identifiers
1 reference